Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details)

v3.22.2
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details) - shares
 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Common Stock Options [Member]    
Antidilutive securities, shares 177,815 11,715
Common Stock Warrants [Member]    
Antidilutive securities, shares 37,083 187,339
Conversion of Convertible Notes and Accured Interest [Member]    
Antidilutive securities, shares 78,584  
Conversion of Series A Stock Inclusive of Cumulative Dividends [Member]    
Antidilutive securities, shares 110,437  
Conversion of Series B Preferred Stock Inclusive of Dividends [Member]    
Antidilutive securities, shares 271,490  
Conversion of Debentures [Member]    
Antidilutive securities, shares   5,469
Conversion Of Series A Stock [Member]    
Antidilutive securities, shares   75,000
Conversion of Series B Preferred Stock [Member]    
Antidilutive securities, shares   390,625
Conversion of Series E-1 Preferred Stock [Member].    
Antidilutive securities, shares   212,500